-
2024-512657-24-00
10
2014-03-27
Acute Lymphoblastic Leukaemia
-
2024-519620-24-01
5
2026-06-01
ANCA-associated vasculitis
-
2025-521702-18-00
1
2026-05-21
Locally advanced unresectable or metastatic colorectal cancer (CRC)
-
2024-517337-41-00
5
2026-05-12
Completely resected Stage IIA-IIIB (N2) KRAS G12C mutated NSCLC
-
2024-519208-29-00
4
2026-04-02
Pleural mesothelioma
-
2024-516643-64-00
5
2026-03-13
Aortic bioprothesis implanted patient for valvular heart disease
-
2025-521634-29-00
5
2026-03-02
Acute Myeloid Leukemia
-
2024-511437-35-00
10
2026-01-05
Patients aged 18-65 years old with newly diagnosed previously untreate
-
2024-514997-27-00
4
2025-12-18
cell penile carcinoma
-
2025-522860-34-00
5
2025-12-16
Chronic lymphocytic leukemia (CLL)
-
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
-
2024-519971-25-00
5
2025-12-03
Advanced MET exon 14 Mutated Non-Small Cell Lung Cancer
-
2025-520927-26-00
5
2025-11-24
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2025-521511-40-00
10
2025-11-18
metastatic non-small cell lung cancer
-
2025-520555-89-00
5
2025-11-14
Metastatic castration-resistant prostate cancer (mCRPC)
-
2024-517411-73-00
6
2025-11-12
Patient with medium or high risk for pneumococcal invasive infection
-
2025-520566-22-00
5
2025-11-10
Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Ca
-
2024-519654-37-00
10
2025-11-07
Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
-
2025-522169-31-00
4
2025-10-30
Adult Patients with HER2-IHC3+ selected solid cancers (endometrial, co
-
2023-504829-39-00
5
2025-10-28
respiratory distress due to upper airway obstruction in child
-
2025-522656-68-00
6
2025-10-15
Metastatic breast cancers
-
2024-517232-22-00
5
2025-09-26
KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorect
-
2024-520386-31-00
5
2025-09-22
Locally Advanced Head & Neck Squamous Cell Carcinoma
-
2024-513171-41-00
5
2025-09-11
Vitiligo